EMV — EMvision Medical Devices Income Statement
0.000.00%
Last trade - 00:00- AU$198.40m
- AU$191.40m
- AU$5.63m
- 29
- 16
- 59
- 26
Annual income statement for EMvision Medical Devices, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.515 | 4.38 | 7.09 | 11.6 | 5.63 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.2 | 10.5 | 10.9 | 13.5 | 13.9 |
| Operating Profit | -9.67 | -6.09 | -3.84 | -1.92 | -8.27 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.4 | -6.11 | -3.87 | -2.03 | -8.36 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -8.4 | -6.11 | -3.87 | -2.73 | -9.81 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.4 | -6.11 | -3.87 | -2.73 | -9.81 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.4 | -6.11 | -3.87 | -2.73 | -9.81 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.12 | -0.081 | -0.05 | -0.034 | -0.115 |